Chat with us, powered by LiveChat

Sirolimus Market (Application - Lymphangioleiomyomatosis (LAM), Organ Transplant Rejection, Sirolimus Coated Balloons, and Catheter Devices; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

Sirolimus Market (Application - Lymphangioleiomyomatosis (LAM), Organ Transplant Rejection, Sirolimus Coated Balloons, and Catheter Devices; Distribution Channel - Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Analysis, Trends, Size, Share and Forecasts to 2025

Report Code: HC0552 Category: Healthcare & Medical Devices Published: June, 2019

A recent report published by Infinium Global Research on sirolimus market provides in-depth analysis of segments and sub-segments in the global as well as regional sirolimus market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional sirolimus market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of global sirolimus market. According to the report, the global sirolimus market is projected to grow at a sluggish CAGR over the forecast period of 2019-2025.

 

Market Insight

Sirolimus is therapeutically used to coat coronary stents, to prevent organ transplant rejection and to treat a rare lung disease lymphangioleiomyomatosis. It works by weakening the body’s immune system and help our body to accept the new organ transplanted in the body. Sirolimus is administered orally in the form of a tablet or solution. Furthermore, sirolimus has antitumor, antifungal, and anti-smooth muscle proliferative roles.

 

The increased rate of kidney transplantation and the occurrence of lifestyle-related diseases are major factors driving the growth of the sirolimus market. According to the U.S. Government, 36,528 kidney transplants were executed worldwide in 2018. Additionally, the growth of improvement in health care infrastructure and worldwide is driving the sirolimus market. This is due to increasing demand, a new target population, and larger emerging markets.  However, adverse effects observed with sirolimus and pending approvals from regulatory bodies are restraining the growth of the sirolimus market. Further research is carried out with advancements in technology and other therapeutic uses of sirolimus, which in turn, providing an opportunity for the growth sirolimus market.

 

Amongst the geographies, the global sirolimus market is segmented in regions like North America, Europe, Asia Pacific, Middle East, and Africa. North America dominates the sirolimus market during the forecast period due to the high prevalence of the lifestyle-related disorder. Furthermore, Europe is expected to have the second largest region for this market and it is estimated to show healthy growth in the forecasting period. It is due to heavy spending on research and development. Asia-Pacific region will grow with a lucrative rate in the forecast period. As increasing expenditure on the healthcare sector in countries like India and China is growing. The growth of pharmaceutical industries and increasing disposable income is expected to aid the growth of the market in the near future.


Global Sirolimus Market

 

Segment Covered

The report on global sirolimus market covers segments such as application and distribution channel. On the basis of application, the sub-markets include lymphangioleiomyomatosis (LAM), organ transplant rejection, sirolimus coated balloons, and catheter devices. On the basis of distribution channel, the sub-markets include hospital pharmacies, retail pharmacies, and online pharmacies.

 

Companies Profiled:

The report provides profiles of the companies in the market such as Intas Pharmaceuticals Ltd, Cadila Healthcare Ltd, Torrent Pharmaceuticals Ltd., Stentys, Concept Medical, Inc., Biocon Limited, Pfizer Inc., and Other Companies.

 

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of sirolimus market. Moreover, the study highlights current market trends and provides forecast from 2019-2025. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.


CHOOSE LICENCE TYPE

Please Choose One of them.

© 2024. Infinium Global Research LLP. All Rights Reserved.